An automated Serious Adverse Event reporting system

被引：0
|
作者：
Lawlor, S [1 ]
Cai, Y [1 ]
Kelley, S [1 ]
Belle, S [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA 15260 USA
来源：
CONTROLLED CLINICAL TRIALS | 2003年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
8
引用
收藏
页码：46S / 47S
页数：2
相关论文
共 50 条
  • [21] Adverse event reporting
    Kruft, Bonnie
    Nelson, Lindsay A.
    Stewart, Jeanette A.
    Stewart, William C.
    [J]. OPHTHALMOLOGY, 2007, 114 (07) : 1420 - 1420
  • [22] An evaluation of the FDA adverse event reporting system and the potential for reporting bias
    Monnot, Andrew D.
    Fung, Ernest S.
    Compoginis, Goli S.
    Towle, Kevin M.
    [J]. JOURNAL OF COSMETIC DERMATOLOGY, 2021, 20 (06) : 1849 - 1854
  • [23] Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the US Food and Drug Administration Adverse Event Reporting System
    Raschi, Emanuel
    Antonazzo, Ippazio Cosimo
    La Placa, Michelangelo
    Ardizzoni, Andrea
    Poluzzi, Elisabetta
    De Ponti, Fabrizio
    [J]. ONCOLOGIST, 2019, 24 (11): : E1228 - E1231
  • [24] Triptans and Serious Cardiovascular Events: Possible Safety Signals from the FDA Adverse Event Reporting System Database
    Roberto, Giuseppe
    Piccinni, Carlo
    Biagi, Chiara
    Koci, Ariola
    Motola, Domenico
    Vaccheri, Alberto
    Montanaro, Nicola
    Poluzzi, Elisabetta
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 438 - 438
  • [25] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [26] A DISPROPORTIONALITY ANALYSIS OF THE SERIOUS ADVERSE DRUG EVENTS ASSOCIATED WITH GENE THERAPY PRODUCTS USING THE FDA ADVERSE EVENT REPORTING SYSTEM (FAERS)
    Ghanem, B.
    Fleming, M.
    Brown, L. M.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S237 - S237
  • [27] Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline
    Chedid, Victor
    Vijayvargiya, Priya
    Camilleri, Michael
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 336 - 338
  • [28] A review of the Vaccine Adverse Event Reporting System database
    Geier, DA
    Geier, MR
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 691 - 698
  • [29] Detecting Signals in the Vaccine Adverse Event Reporting System
    Broder, Karen
    Haber, Penina
    Miller, Elaine
    DeStefano, Frank
    Vellozzi, Claudia
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S358 - S358
  • [30] THE VACCINE-ADVERSE-EVENT-REPORTING-SYSTEM (VAERS)
    CHEN, RT
    RASTOGI, SC
    MULLEN, JR
    HAYES, SW
    COCHI, SL
    DONLON, JA
    WASSILAK, SG
    [J]. VACCINE, 1994, 12 (06) : 542 - 550
12345